Arvinas (ARVN) Revenue (2017 - 2026)

Arvinas (ARVN) posted quarterly Revenue of $15.6 million for Q1 2026, down 91.74% year-over-year from $188.8 million in Q1 2025, and up 64.21% quarter-over-quarter from $9.5 million in Q4 2025.

Arvinas (ARVN) Revenue (2017 - 2026) Analysis & Trends

Arvinas' Revenue history runs 10 years deep, the most recent figure standing at $15.6 million for Q1 2026.

  • In Q1 2026, Revenue fell 91.74% year-over-year to $15.6 million; the TTM figure through Mar 2026 stood at $89.4 million (down 79.06% YoY), while the FY2025 annual figure was $262.6 million, changed 0.3% from the prior year.
  • Revenue for Q1 2026 stood at $15.6 million, up from $9.5 million in the prior quarter.
  • The five-year high for Revenue was $188.8 million in Q1 2025, with the low at -$43.1 million in Q4 2023.
  • The 5-year median for Revenue is $33.8 million (2022), against an average of $44.2 million.
  • The sharpest annual moves came in 2023 and 2025: Revenue sank 214.02% in 2023, then surged 646.25% in 2025.
  • Arvinas' Revenue stood at $37.8 million in 2022, then tumbled by 214.02% to -$43.1 million in 2023, then jumped by 237.35% to $59.2 million in 2024, then slumped by 83.95% to $9.5 million in 2025, then surged by 64.21% to $15.6 million in 2026.
  • Business Quant data shows ARVN's Revenue at $15.6 million in Q1 2026, $9.5 million in Q4 2025, and $41.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 Arvinas 585.74 Mn 17.84 Mn - 249.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 249.70 Mn
Mar 31, 2026 15.60 Mn
Dec 31, 2025 9.50 Mn
Sep 30, 2025 41.90 Mn
Jun 30, 2025 22.40 Mn
Mar 31, 2025 188.80 Mn
Dec 31, 2024 59.20 Mn
Sep 30, 2024 102.40 Mn
Jun 30, 2024 76.50 Mn
Mar 31, 2024 25.30 Mn
Dec 31, 2023 -43.10 Mn
Sep 30, 2023 34.60 Mn
Jun 30, 2023 54.50 Mn
Mar 31, 2023 32.50 Mn
Dec 31, 2022 37.80 Mn
Sep 30, 2022 33.20 Mn
Jun 30, 2022 33.80 Mn
Mar 31, 2022 26.50 Mn
Dec 31, 2021 33.20 Mn
Sep 30, 2021 9.30 Mn